1	Receiving a stable dose of one of the following AEDs carbamazepine/oxcarbazepine lamotrigine levetiracetam or valproic acid The AED dose must be stable 4 weeks prior to start of collection of baseline seizure data retrospective or prospective and during the Baseline period|levetiracetam[93,106]|||||||||C0377265|114477|114477|levetiracetam
1	Receiving a stable dose of one of the following AEDs carbamazepine/oxcarbazepine lamotrigine levetiracetam or valproic acid The AED dose must be stable 4 weeks prior to start of collection of baseline seizure data retrospective or prospective and during the Baseline period|lamotrigine[81,92]|||||||||C0064636|28439|28439|lamotrigine
1	Receiving a stable dose of one of the following AEDs carbamazepine/oxcarbazepine lamotrigine levetiracetam or valproic acid The AED dose must be stable 4 weeks prior to start of collection of baseline seizure data retrospective or prospective and during the Baseline period|carbamazepine / oxcarbazepine[53,80]|||||||||C0006949|2002|2002|carbamazepine
1	Receiving a stable dose of one of the following AEDs carbamazepine/oxcarbazepine lamotrigine levetiracetam or valproic acid The AED dose must be stable 4 weeks prior to start of collection of baseline seizure data retrospective or prospective and during the Baseline period|valproic acid[110,123]|||||||4 weeks[152,159]||C0042291|11118|11118|valproic acid
